Atlas Trials

Investigating a Personalized Approach to Anti-Platelet Therapy

Clinical trial NCT07602257 · NOT_YET_RECRUITING

Trial details

NCT number
NCT07602257
Sponsor
Ottawa Heart Institute Research Corporation
Status
NOT_YET_RECRUITING
Phase
Phase 4
Study type
INTERVENTIONAL
High Risk Bleeding
Start date
2026-06-01
Primary completion
2029-12-28
Enrollment
1760

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.